News

Search news

There are 24 results.

Report and presentations 2nd EU Compass Forum on Mental Health and Well-being online

The 2nd EU Compass Forum on Mental Health and Well-being took place in Luxembourg on 8-9 June 2017. The event was attended by diverse stakeholders such as policy makers and EU Member State representatives, non-governmental stakeholders from advocacy groups and care organisations, as well as mental health care providers, professionals, and service users.

Read more


"Play of Drug Policy Making in Tajikistan” with an expert from the Trimbos Institute (CADAP Component 1 – National Drug Strategy)

The Central Asia Drug Action Programme’s (CADAP) national partners discussed the assessment report “State of Play of Drug Policy Making in Tajikistan” with an expert from the Trimbos Institute (CADAP Component 1 – National Drug Strategy).

Read more


Assessment reports on the state of play of drug policy making in Central Asia have been published by CADAP

For the first time, the Central Asia Drug Action Programme Phase 6 (CADAP 6) sets out proposals for reviewing and supporting the development of strategies, action plans and legislations employing European good practices.

Read more


High level conference on tobacco and research

On June 20, 2017, the Smoke Free Partnership organized and hosted a high level conference on tobacco and research in Brussels. One of the primary goals of the meetings was to address gaps in tobacco research, develop relationships and partnerships between tobacco control researchers, and discuss how tobacco control research can promoted and further developed at the European level.

Read more


Annual Franz Trautmann memorial lecture ISSDP

In memory of Franz Trautmann's significant contribution to international drug policy research and to the development of the International Society for the Study of Drug Policy, the Society has decided to hold a Franz Trautmann memorial lecture at each of its annual conferences. This will be a lecture from a high profile researcher who reflects Franz's commitment to using excellent research to improve drug policy through international collaboration.

Read more